Since 1995, Reliable Business Intelligence for Clinical Laboratories, Pathology Groups and Laboratory Diagnostics

Search

Commentary and Opinion by R. Lewis Dark

Doom And Gloom Versus Optimism

COUNT ME AS ONE WHO IS NOT SURPRISED THAT SEVERAL of healthcare’s billion-dollar corporations have posted huge losses. I may be at the age of retirement, and I might be guilty of values and ethics often labeled as “old fashioned,” but I am possessed with common sense. Those of our clients carefully following news stories […]

To access this post, you must purchase The Dark Report.

Doom And Gloom Versus Optimism Read More »

Are Pathologists The Next “Fish In The Barrel?”

“SHOOTING FISH IN THE BARREL” MAY BE A GOOD METAPHOR TO DESCRIBE what can soon happen to the profession of pathology. This issue of THE DARK REPORT covers several important stories on laboratory management, with direct consequences to pathologists. First, the ISO 9001 certification of the Nichols Institute division of Quest Diagnostics Incorporated (see pages

To access this post, you must purchase The Dark Report.

Are Pathologists The Next “Fish In The Barrel?” Read More »

Executive War College Goes International

IT MAY SURPRISE MANY PEOPLE TO LEARN THAT THIS YEAR’S Executive War College in New Orleans attracted registrants from New Zealand and Germany. What may be even more surprising is the reason they traveled from overseas to come to this particular program. Our editor met with them and learned some intriguing and useful things that I

To access this post, you must purchase The Dark Report.

Executive War College Goes International Read More »

Serendipity Or Response To Market Forces?

THIS ISSUE OF THE DARK REPORT IS A GREAT EXAMPLE of how marketplace developments shape what we write. After the Executive War College in New Orleans, I spoke with our Editor, Robert Michel. We discussed his impressions from the collective information of 26 presentations. We also discussed what he had learned from conversations with the attendees,

To access this post, you must purchase The Dark Report.

Serendipity Or Response To Market Forces? Read More »

Where Do We Go From Here?

THIS IS WRITTEN FOR BOTH LABORATORIANS COMING TO THE DARK REPORT’S Executive War College in New Orleans next week as well as those not attending. As I look at the registration list, I see a diverse range of attendees. Registered for this year’s event are CEOs of public laboratories and owners of independent commercial laboratories. Hospital

To access this post, you must purchase The Dark Report.

Where Do We Go From Here? Read More »

Doctors, Hospitals & HMOs Take Their Turn

IT MAY BE PREMATURE OF OUR EDITOR TO PREDICT that increasing numbers of HMOs will choose to withdraw from state Medicaid programs during the next 24 months. (See pages 4-6.) But I do think he is on target with his observations that hospitals, physicians, and insurance companies will not let government healthcare regulators push them

To access this post, you must purchase The Dark Report.

Doctors, Hospitals & HMOs Take Their Turn Read More »

Regionalization And Consolidation Continue

STORIES IN THIS ISSUE REVEAL HOW PERVASIVE THE TRENDS of regionalization and consolidation are. Whether one agrees or disagrees that managed care is the future of healthcare, it is obvious that regionalization and consolidation will continue to transform healthcare. Consolidation transformed the commercial laboratory industry. Consolidation is now transforming hospitals, directly impacting hospital- based laboratories.

To access this post, you must purchase The Dark Report.

Regionalization And Consolidation Continue Read More »

Consumer Choice Decimates HMO Business Plan

I ENCOURAGE YOU TO CAREFULLY READ THE STORY about the financial woes of managed care plans in this issue. After virtually every big HMO company reported sizeable losses for 1997, Kaiser Permanente joined the club with a $270 million loss. Following years of soaring profits, it appears that health insurers are about to enter a sustained

To access this post, you must purchase The Dark Report.

Consumer Choice Decimates HMO Business Plan Read More »

Rate of Change Follows a Geometric Curve

JANUARY WAS A WILD MONTH FOR COMPANIES OFFERING automated cytology products. January opened with new CPT codes for automated cytology procedures taking effect. January closed with news that the FDA’s advisory panel, convened on January 28, recommended approval of the PMA supplement of NeoPath, Inc.’s automated cytology instrument for primary screening of Pap smears. Do not

To access this post, you must purchase The Dark Report.

Rate of Change Follows a Geometric Curve Read More »

;